The company you have never heard of makes the toothpaste, painkillers and vitamins you buy without thinking. Here is how GSK's cast-off brands became a £30 billion bet on self-care.
Pineapple Products is a direct-to-consumer health supplement company that builds and operates a portfolio of consumer wellness brands. Founded by Brett Allcorn, it started as classroom seminars in New York City and grew into a house of brands that pairs original product formulations - including probiotics with unique metabolic strains - with strong storytelling and partnerships with doctors, personalities, and influencers. The company creates, markets, and oversees smaller brands under a single parent, aiming to build products it believes don't yet exist in the market.
Oshi Health is a virtual-first gastrointestinal care clinic that gives the roughly one in four Americans living with digestive disorders fast access to a coordinated team of GI providers, registered dietitians, behavioral health specialists, and care coordinators. Available in all 50 states as an in-network benefit, Oshi pairs unlimited virtual visits and messaging with evidence-based, whole-person treatment - an approach a national health plan's analysis tied to 92% symptom improvement, 98% patient satisfaction, and more than $10,000 in medical cost savings per patient over six months.
OLIPOP is a prebiotic soda company that turned the soft drink industry on its head by proving that soda can be both delicious and good for your gut. Founded in 2018 by Ben Goodwin and David Lester, the Oakland-based company combines nostalgic flavors with functional ingredients - each can delivers 6-9 grams of prebiotic fiber from plant-based sources like cassava root, chicory root, and nopal cactus. After reaching $400 million in revenue and profitability in 2024, OLIPOP closed a $50 million Series C at a $1.85 billion valuation in 2025, making it the fastest-growing non-alcoholic beverage brand in the United States.